跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,383 条关于
“MASLD/MASH”
全部
4,383
临床试验
3,704
药物
40
机构
6
资讯
633
去年
Sagimet Advances Denifanstat into Phase 3 Trials for MASH and MASLD Following FDA Feedback
去年
Sagimet's Denifanstat Advances to Phase 3 for MASH Following FDA Interactions
去年
Sagimet's Denifanstat Receives FDA Breakthrough Therapy Designation for MASH
去年
MASH and MASLD Underdiagnosed in the US, True Prevalence Higher Than Claims Data Suggests
10个月前
FDA Grants Accelerated Approval for Semaglutide in MASH Treatment, but Equity Gaps Persist in Clinical Trials
上个月
World Hepatitis Day Research Topics Highlight Gaps in Diagnosis, Treatment Access, and Pediatric Elimination of Viral Hepatitis
去年
Sagimet's Denifanstat Advances to Phase III Trials for MASH Treatment
去年
Sagimet's Denifanstat Advances to Phase III Trials for MASH Treatment
去年
Sagimet Biosciences' Denifanstat Gains FDA Breakthrough Therapy Designation for MASH
去年
GI Alliance Launches MASLD Clinical Trials at Two Dallas-Fort Worth Locations
第 1 页,共 64 页
上一页
下一页